An analysis found that MS patients on a less frequent anti-CD20 therapy dosing schedule do not have more relapses or show ...
PHOENIX — Two new datasets support the use of potent disease-modifying therapies (DMTs) during pregnancy in women with active multiple sclerosis (MS), reinforcing a growing shift toward treatment when ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback